Physical Exercise for Cognitive Rehabilitation of Patients With Bipolar Affective Disorder
Physical Exercise for Cognitive Rehabilitation of Patients With Bipolar Affective Disorder: a Controlled and Randomized Study
The goal of this clinical trial is to evaluate the impact of Physical Exercise (PE), as an adjuvant treatment, on the cognition of patients diagnosed with Bipolar Disorder who present cognitive impairments, as well as its impact on quality of life and functionality and its association with physiological variables.
Our specific goals are:
- Evaluate the effect of PE on the neuropsychological functions of attention, memory, verbal fluency, executive function and processing speed in patients diagnosed with BD who present cognitive impairments in these domains.
- To evaluate the effect of PE on the quality of life and functionality of patients diagnosed with BD, as well as possible associations with cognitive functions.
- To evaluate possible correlations between physiological variables, such as cardiorespiratory indices, strength and body composition, and improvements in cognitive functions, quality of life and functionality.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Gabriel Okawa Belizario
- Phone Number: +55 (11) 963391570
- Email: gabrielokawabelizario@gmail.com
Study Contact Backup
- Name: Beny Lafer, M.D, Ph.D
- Email: benylafer@gmail.com
Study Locations
-
-
São Paulo
-
São Paulo, São Paulo, Brazil, 05403-903
- Recruiting
- Gabriel Okawa Belizario
-
Contact:
- Gabriel Belizario
- Phone Number: +55 (11)963391570
- Email: gabrielokawabelizario@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of Bipolar disorder (BD) I and II according to DSM-5
- Age: 18 - 55 years old
- Complete primary education
- Euthymic (YMRS < 8 and MADRS < 12)
- Presence of cognitive impairments (COBRA > 14 and SCIP < 75)
- Estimated IQ ≥ 80
- No medication changes in the last month
- Having been without regular PE practice for six months
- Signature of the TCLE
Exclusion Criteria:
- Organic mental disorder
- BMI > 40
- Alcohol or drug abuse in the last 6 months
- Use of benzodiazepines or beta-blockers in the last month
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Intervention Group
The experimental group will be submitted to supervised training sessions, three times per week, for 12 weeks, of aerobics exercises, as well as treatment as usual (TAU)
|
Measure the impact of physical exercise in the cognition of pacients diagnosed with Bipolar Disorder
|
|
No Intervention: Control Group
the control group will be submitted exclusively to treatment as usual (TAU)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Montgomery-Asberg Depression Rating Scale (MADRS)
Time Frame: Baseline, Week 4, Week 8 and Follow-up (12 weeks)
|
Scale used to assess the presence and intensity of depressive symptoms.
|
Baseline, Week 4, Week 8 and Follow-up (12 weeks)
|
|
Young Mania Rating Scale (YMRS)
Time Frame: Baseline, Week 4, Week 8 and Follow-up (12 weeks)
|
Scale used to assess the presence and intensity of manic symptoms.
|
Baseline, Week 4, Week 8 and Follow-up (12 weeks)
|
|
Cognitive Complaints in Bipolar Disorder Rating Assessment (COBRA)
Time Frame: Baseline only
|
Screening scale for the presence of cognitive deficits.
Suggested cutoff point is 14
|
Baseline only
|
|
Screen for Cognitive Impairment in Psychiatry (SCIP)
Time Frame: Baseline only
|
Subjective screening scale for difficulties associated with cognitive impairment.
Suggested cutoff point is 70
|
Baseline only
|
|
Stroop Color-Word Test (Spreen and Strauss, 1998)
Time Frame: Baseline and Follow-up (12 weeks)
|
Assessing mental flexibility and inhibitory control (attention and executive function)
|
Baseline and Follow-up (12 weeks)
|
|
Verbal Fluency - F.A.S (Spreen and Strauss, 1998)
Time Frame: Baseline and Follow-up (12 weeks)
|
Assessing verbal fluency, inhibitory control and the correct use of strategies (executive function)
|
Baseline and Follow-up (12 weeks)
|
|
Trail Making Test (Spreen and Strauss, 1998)
Time Frame: Baseline and Follow-up (12 weeks)
|
Assessing alternating attention
|
Baseline and Follow-up (12 weeks)
|
|
Logical Memory I and II (Wechsler, 1997b)
Time Frame: Baseline and Follow-up (12 weeks)
|
Assessing verbal memory
|
Baseline and Follow-up (12 weeks)
|
|
List of Words (Wechsler, 1997a)
Time Frame: Baseline and Follow-up (12 weeks)
|
Assessing learning capacity and attention
|
Baseline and Follow-up (12 weeks)
|
|
Cardiovascular evaluation
Time Frame: Baseline and Follow-up (12 weeks)
|
All patients will undergo an electrocardiogram computerized.
|
Baseline and Follow-up (12 weeks)
|
|
Stress test on the treadmill
Time Frame: Baseline and Follow-up (12 weeks)
|
A treadmill stress test will be performed.
|
Baseline and Follow-up (12 weeks)
|
|
Respiratory gas exchange analysis (ergospirometric)
Time Frame: Baseline and Follow-up (12 weeks)
|
A computerized gas exchange analysis system will be used (CPX/ULTIMA, Medgraphics®, Saint Paul, MN, USA)
|
Baseline and Follow-up (12 weeks)
|
|
Isokinetic Strength Test
Time Frame: Baseline and Follow-up (12 weeks)
|
The isokinetic test will be performed on the lower limbs (extensor and flexor muscles of the knee joints) on the dominant (R) and non-dominant (ND) leg at an angular velocity of 60 s -1 using a computerized isokinetic dynamometer (Biodex®, Inc .
USA).
|
Baseline and Follow-up (12 weeks)
|
|
Body composition by bioimpedance
Time Frame: Baseline and Follow-up (12 weeks)
|
Body composition measurements will be obtained by the non-invasive indirect bioimpedance method using a scale
|
Baseline and Follow-up (12 weeks)
|
|
Anthropometric measurements (skinfolds) and calculation of body composition
Time Frame: Baseline and Follow-up (12 weeks)
|
Body mass (BM) will be measured on a Filizola mechanical scale, with an accuracy of 0.1 kg.
Height will be determined using a stadiometer, attached to the scale, with an accuracy of 0.1cm (Gordon et al., 1988).
Body composition will be determined using the skinfold thickness technique.
|
Baseline and Follow-up (12 weeks)
|
|
One Repetition Maximum Test (1RM)
Time Frame: Baseline and Follow-up (12 weeks)
|
The exercises to be tested are the seated bench press (pectoral muscles), leg-press (quadriceps and glutes), rowing (dorsal muscles), standing knee bending chair (hamstrings), abdominal (rectus and abdominal obliques).
|
Baseline and Follow-up (12 weeks)
|
|
Wechsler Abbreviated Scale of Intelligence (WASI)
Time Frame: Baseline and Follow-up (12 weeks)
|
delivers an estimation of a student's general intellectual ability by measuring the verbal, nonverbal, and general cognition of individuals from 6 to 89 years of age.
|
Baseline and Follow-up (12 weeks)
|
|
Digit Span Memory Test
Time Frame: Baseline and Follow-up (12 weeks)
|
short test that evaluates a person's memory and cognitive status
|
Baseline and Follow-up (12 weeks)
|
|
Cognitive Emotion Regulation Questionnaire (CERQ)
Time Frame: Baseline and Follow-up (12 weeks)
|
Questionnaire measuring cognitive coping strategies
|
Baseline and Follow-up (12 weeks)
|
|
Difficulties in Emotion Regulation Scale (DERS)
Time Frame: Baseline and Follow-up (12 weeks)
|
Instrument measuring emotion regulation problems
|
Baseline and Follow-up (12 weeks)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Assessment Staging Tool (FAST)
Time Frame: Baseline and Follow-up (12 weeks)
|
Scale used to assess the patient's global functionality.
|
Baseline and Follow-up (12 weeks)
|
|
The World Health Organization Quality of Life Assessment (WHOQOL)
Time Frame: Baseline and Follow-up (12 weeks)
|
Scale used to assess patients quality of life.
|
Baseline and Follow-up (12 weeks)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Beny Lafer, M.D, Ph.D, University of Sao Paulo
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 05440818.0.0000.0068
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.